Induction | Vaginal insert (n = 116) | Oral tablets (n = 172) | 5% p-value |
---|---|---|---|
Age (years), mean (SD) | 27.8 (5.0) | 27.5 (5.2) | 0.62 |
BMI (kg/m2) mean (SD) | 27.7 (8.4) | 29.5 (6.8) | 0.06 |
Cigarette use, n (%) | 20 (17) | 26 (15) | 0.62 |
Pre-existing medical conditions, n (%) | 12 (10.3) | 22 (12.8) | 0.53 |
Pre-existing psychiatrical conditions, n (%) | 12 (10.3) | 17 (9.9) | 0.90 |
Pregnancy-related medical conditions, n (%) | 31 (26.7) | 84 (48.8) | 0.002 |
Gestational diabetes, n (%) | 1 (0.9) | 37 (21.5) | < 0.001 |
Preeclampsia, n (%) | 16 (13.8) | 24 (13.9) | 0.97 |
Hypertension, n (%) | 2 (1.7) | 11 (6.4) | 0.06 |
Intrahepatic cholestasis, n (%) | 3 (2.6) | 5 (2.9) | 0.87 |
Others, n (%) | 9 (7.8) | 7 (4.1) | 0.18 |
Indication for induction, n (%) | |||
Medical/Obstetrical | 45 (39) | 107 (62.2) | < 0.001 |
Post-datesa | 57 (49) | 54 (31.4) | 0.002 |
Other | 13 (11.2) | 11 (6.4) | 0.15 |
Bishop score, mean (SD) | 3.2 (1.5) | 4.3 (2.1) | < 0.001 |
Gestational age at delivery (w + d), mean (SD) | 40 + 5 (1 + 3) | 40 + 5 (1 + 3) | 1 |
Birthweight (g), mean (SD) | 3636 (511) | 3646 (566) | 0.88 |